Cingulate Inc. (CING)

NASDAQ: CING · USD

$5.14

-0.39 (-7.0%)· Recorded snapshot

Market cap	74.7M
Net income (ttm)	-28.8M
EPS (ttm)	-$3.28
Shares out	14.5M
Volume	206,595
Beta	-0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -28.8M
EPS (ttm): -$3.28
Market cap: 74.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-198.7

P25 n/aP50 n/aP75 n/a

ROIC-74.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CING indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001862150
Company name	Cingulate Inc.
Country	United States
Country code	US
CUSIP number	17248W303
Earnings date	2026-11-12
Earnings time	bmo
Employees	14
Employees change	1
Employees growth	7.69%
Enterprise value	$52.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Biotechnology
IPO date	2021-12-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US17248W3034
Last 10-K release date	2026-03-18
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2024-08-09
Last stock split type	Reverse
Market cap	$74.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$5.14
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CING
U.S. state	Kansas
Website	https://www.cingulate.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-63.81%
FCF / EV yield	-35.91%
FCF yield	-26.04%
Forward EV/Sales	5.45x
Forward P/S	7.52x
P/B ratio	3.27x
Price / tangible book value	3.43x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-2.1M
ROA	-66.94%
ROA (5Y)	-95.87%
ROCE	-101.98%
ROE	-198.74%
ROIC	-74.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-284,476
Depreciation and amortization	$448,042
EBIT	$-24.9M
EBITDA	$-24.5M
EPS	$-3.28
FCF per share	$-1.44
Financing cash flow	$40.4M
Free cash flow	$-20.9M
Free cash flow minus SBC	$-22.9M
Gross profit	$-8.5M
Investing cash flow	$-284,476
Net borrowing	$5.3M
Net cash flow	$19.5M
Net income	$-28.8M
Operating cash flow minus SBC	$-22.6M
Operating income	$-24.9M
Stock-based compensation	$1.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$1.69
Debt / equity	0.27
Interest coverage	-11.47
Long-term assets	$2.9M
Long-term liabilities	$968,455
Net cash (debt)	$22.1M
Net cash / market cap	27.5%
Net cash growth	853.72%
Net debt / equity	-0.94
Piotroski F-Score	2
Property, plant and equipment	$2.9M
Shareholders' equity	$23.5M
Tangible book value	$23.5M
Tangible book value per share	$1.69
Total assets	$33.1M
Total cash	$28.4M
Total debt	$6.3M
Total liabilities	$9.6M
WACC	1.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$30.2M
Current liabilities	$8.6M
Current ratio	3.5
Net working capital	$-1.5M
Quick ratio	3.3
Working capital	$21.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-167.56%
Dividend yield	0%
Shareholder yield	-167.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.04
1D price change	-7.05%
1M price change	7.25%
1M total return	7.25%
1W price change	14.35%
1W total return	14.35%
1Y price change	37.77%
1Y return CAGR	37.8%
1Y total return	37.77%
20-day SMA	$4.79
200-day SMA	$5.44
3M price change	14.6%
3M total return	14.6%
3Y price change	-94.74%
3Y return CAGR	-62.51%
3Y total return	-94.74%
50-day SMA	$5.03
50-day SMA vs 200-day SMA	50under200
52-week high	$11.89
52-week high date	2026-03-17
52-week low	$3.16
52-week low date	2026-06-01
6M price change	-1.52%
6M total return	-1.52%
All-time high	$1,236.00
All-time high date	2021-12-08
All-time low	$1.80
All-time low date	2024-08-14
Average true range (ATR)	$0.30
Average volume	117.6K
Beta (1Y)	0.06
Beta (2Y)	0.33
Beta (5Y)	-0.88
Change from 52-week high	-56.77%
Change from 52-week low	62.66%
Change from all-time high	-99.58%
Change from all-time low	187.78%
Change from open	-5.69%
Day's gap	-1.45%
Dollar volume	$1.1M
High price	$5.45
Low price	$4.95
Monthly RSI	37
Open price	$5.45
Position in 52-week range	38%
Premarket change	-1.45%
Premarket close	$5.53
Premarket price	$5.45
Premarket volume	1.6K
Previous close	$5.53
Price vs 150-day SMA	2.72%
Price vs 20-day SMA	8.19%
Price vs 200-day SMA	-4.76%
Price vs 50-day SMA	2.92%
Relative volume	1.76
Return from IPO open	-99.54%
Return from IPO price	-7.83%
RSI	57.9
Sharpe ratio	0.76
Sharpe ratio (3Y)	0.26
Sortino ratio	1.21
Sortino ratio (3Y)	0.75
Volume	206.6K
Weekly RSI	51.74
YTD price change	19.36%
YTD total return	19.36%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14.2M
Float percentage	97.67%
Shares change (QoQ)	34.86%
Shares change (YoY)	167.56%
Shares held by insiders	0.92%
Shares held by institutions	28.24%
Shares outstanding	14.5M
Short % of float	7.16%
Short % of shares	6.99%
Short ratio	10.5 days

Deeper analysis on CING

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CING report

Is a complete CING research report available?

No complete published report is available for Cingulate Inc. (CING) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cingulate Inc. (CING)

Price

Financial snapshot

Fair-value bridge

Latest news · CING

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CING indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CING

Frequently asked questions